Sharon Stevenson
Co-Founder & Managing Director @ Okapi Venture Capital
Orange, United States
Sharon Stevenson is a Series A investor at Okapi Venture Capital in Orange focused on Medical and Health Care. Sharon Stevenson is the Program Manager of the National Hospice and Palliative Care Organization. She attended the University of California, Davis.
- Total investments:
- 12
- Last investment:
- Lead investor:
- 25%
Last updated:
For AI agents: llms.txt
Industries Sharon Stevenson invests in
Stages Sharon Stevenson invests in
Countries Sharon Stevenson invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 4 (33%)
- Health Care 4 (33%)
- Biotechnology 4 (33%)
- Medical Device 3 (25%)
- SaaS 2 (17%)
Stage
- Series A 4 (33%)
- Series B 2 (17%)
- Seed 1 (8%)
- Series C 1 (8%)
- Series E 1 (8%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Welltok is a data-driven, enterprise SaaS company that delivers the healthcare industry’s leading consumer activation platform. Welltok’s solutions empower health plans, employers, providers, and public entities to connect consumers with personalized health improvement resources, making it easy and rewarding for consumers to complete actions thatoptimize their health and wellbeing. The company was founded in 2009 and headquartered in Denver, Colorado. | $33.7M / Series E / Oct 05, 2016 | ||
| Focal Therapeutics is a medical device company that was established to help surgeons, radiation oncologists, and other clinicians to clearly identify a surgical site through the use of an innovative tissue marker.The company’s BioZorb™ tissue marker is an implantable device placed by surgeons that delineates the site of tissue removal in threedimensions. BioZorb is applicable to virtually all forms of radiation therapy and assists physicians in treatment planning, patient positioning during treatment, and long-term follow-up.Focal Therapeutics’ leadership team has a long track record in the development and commercialization of medical devices, particularly in the field of breast cancer care. As such, the company has chosen to offer BioZorb initially to surgeons and radiation oncologists who treat breast cancer patients. | $7.8M / Sep 03, 2014 | ||
| BioTrace Medical is dedicated to reinventing temporary pacing to improve patient outcomes and reduce hospital costs. BioTrace Medical is a stealth-stage company focused on the production of medical devices. The company was founded by Aravind Swaminathan and Ellis Garai in 2013 and is based in San Mateo, California. | $3.5M / Series A / Feb 25, 2014 | ||
| Welltok is a data-driven, enterprise SaaS company that delivers the healthcare industry’s leading consumer activation platform. Welltok’s solutions empower health plans, employers, providers, and public entities to connect consumers with personalized health improvement resources, making it easy and rewarding for consumers to complete actions thatoptimize their health and wellbeing. The company was founded in 2009 and headquartered in Denver, Colorado. | $22.1M / Series C / Feb 11, 2014 | ||
| WiserCare develops healthcare decision support solutions. It offers a patented Web-based software-as-service solution that provides personalized reports that include evidence-based treatment options, personal values, and preferences regarding patients’ treatment options; and details to patients about the success rates of each treatment andassociated side effects. The company offers its solutions for hospitals, integrated delivery systems, ACOs, and health plans. WiserCare is based in Los Angeles, California. | $2M / Seed / Dec 20, 2013 | ||
| Welltok is a data-driven, enterprise SaaS company that delivers the healthcare industry’s leading consumer activation platform. Welltok’s solutions empower health plans, employers, providers, and public entities to connect consumers with personalized health improvement resources, making it easy and rewarding for consumers to complete actions thatoptimize their health and wellbeing. The company was founded in 2009 and headquartered in Denver, Colorado. | $18.7M / Series B / Apr 10, 2013 | ||
| Welltok is a data-driven, enterprise SaaS company that delivers the healthcare industry’s leading consumer activation platform. Welltok’s solutions empower health plans, employers, providers, and public entities to connect consumers with personalized health improvement resources, making it easy and rewarding for consumers to complete actions thatoptimize their health and wellbeing. The company was founded in 2009 and headquartered in Denver, Colorado. | $5M / Series A / Aug 24, 2011 | ||
| PathCentral, an Irvine, California-based provider of a fully integrated, web-based enterprise software platform designed specifically for community pathologists. Created by a team of pathologists and industry executives, PathCentral's solution integrates all aspects of a pathology practice's business, including ordering (accessioning),barcode-based laboratory workflow management and specimen tracking, transcription, test send-outs, professional consultations, diagnosis, reporting, billing and financial analysis. | $10M / Series B / Nov 02, 2010 | ||
| OrthAlign is a privately-held medical device company providing healthier and more pain-free lifestyles to joint replacement patients. The company is developing a line of computer-assisted surgical devices that distill the critical features and benefits of large surgical navigation systems. Its goal is to create a new standard of care in total jointreplacement, making consistent, and measurable results accessible to surgeons and patients.The company was founded in 2009 and based in Aliso Viejo, California. | $5.2M / Series A / Mar 15, 2010 | ||
| OrthAlign is a privately-held medical device company providing healthier and more pain-free lifestyles to joint replacement patients. The company is developing a line of computer-assisted surgical devices that distill the critical features and benefits of large surgical navigation systems. Its goal is to create a new standard of care in total jointreplacement, making consistent, and measurable results accessible to surgeons and patients.The company was founded in 2009 and based in Aliso Viejo, California. | $7.2M / Series A / Jan 07, 2009 | ||
| See all 12 investments → | |||
Co-Investors
About Okapi Venture Capital
Okapi Venture Capital provides long-term capital and management support to emerging businesses in the information technology and life science sectors. They take pride in partnering with exceptionally talented entrepreneurs and operational executives to develop valuable high growth businesses.They are currently managing Okapi Ventures I, LP - aventure capital fund chartered to invest in seed and early-stage information technology and life science companies along the Tech Coast that is southern California with a particular emphasis on Orange County startups.
Okapi Venture Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Jeff Bocan
Partner
|
|||
John Waller
Partner
|
|||
Marc Averitt
Co-Founder & Managing Director
|
|||
Matthew McRae
Venture Partner
|
|||
|
Sharon Stevenson
Co-Founder & Managing Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Sharon Stevenson invest in?
Sharon Stevenson invests primarily in Medical, Health Care and Biotechnology startups, most often at Series A and Series B stage. Most of the 12 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Sharon Stevenson?
Public channels for Sharon Stevenson include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Sharon Stevenson last invest?
The most recent investment recorded for Sharon Stevenson closed in Oct 2016. Shizune tracks 12 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
